| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |